Shopping Cart
Remove All
Your shopping cart is currently empty
Bimekizumab
😃Good
Catalog No. T76798Cas No. 1418205-77-2
Alias THPTA
Bimekizumab is a humanised monoclonal antibody targeting IL17A/IL17F, capable of reducing IL17A/IL17F levels and blocking inflammation-driven osteoblast differentiation. It is applicable for investigating psoriasis and arthritis.
Bimekizumab
Bimekizumab
😃Good
Catalog No. T76798Alias THPTACas No. 1418205-77-2
Bimekizumab is a humanised monoclonal antibody targeting IL17A/IL17F, capable of reducing IL17A/IL17F levels and blocking inflammation-driven osteoblast differentiation. It is applicable for investigating psoriasis and arthritis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $373 | - | In Stock | |
| 5 mg | $788 | - | In Stock | |
| 10 mg | $1,230 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:>95.0% (SDS-PAGE)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Bimekizumab is a humanised monoclonal antibody targeting IL17A/IL17F, capable of reducing IL17A/IL17F levels and blocking inflammation-driven osteoblast differentiation. It is applicable for investigating psoriasis and arthritis. |
| In vitro | Methods: Bimekizumab (10 μg/mL, 1 hour) was used to treat human periosteum-derived cells (hPDCs), and the expression of osteogenesis-related genes was analyzed by real-time quantitative PCR. Results: Bimekizumab effectively suppressed the expression of osteogenic genes through dual neutralization of IL-17A and IL-17F.[1] |
| Synonyms | THPTA |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | IL-17a & IL-17f |
| Molecular Weight | 147.24 kDa |
| Cas No. | 1418205-77-2 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature,keep away from direct sunlight | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Bimekizumab | purchase Bimekizumab | Bimekizumab cost | order Bimekizumab | Bimekizumab in vitro | Bimekizumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.